Greater Southern California Node of the Clinical Trials Network
临床试验网络大南加州节点
基本信息
- 批准号:10173176
- 负责人:
- 金额:$ 12.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAdministrative SupplementAlcohol or Other Drugs useAttitudeCOVID-19COVID-19 pandemicCaliforniaCaringClinicClinical Trials NetworkCollectionCommunitiesCommunity HealthDataData AnalysesData CollectionDevelopmentElectronic Health RecordEpidemicEvolutionFeasibility StudiesFocus GroupsFundingFutureGoalsHealthHealth PersonnelHealth Services AccessibilityHealth StatusHealthcareHealthcare SystemsIdahoIndividualInterviewInvestigationKnowledgeLicensingMaineMeasuresModelingOpiate AddictionOpioidParentsParticipantPatient Self-ReportPatientsPerceptionPeriodicityPharmaceutical PreparationsPhasePrimary Health CareProviderPublic HealthRegulationReportingResearchRuralRural CommunityScanningSeaServicesShapesSiteStructureSurveysSymptomsSystemTechnologyTelemedicineTelephoneTimeTimeLineTravelTreatment outcomeTrustUncertaintyVendorVideoconferencingWashingtonbarrier to carecoronavirus diseaseimprovedinterestopioid use disorderpandemic diseaseparent projectpatient health informationpatient populationpragmatic trialprimary care settingrecruitremote health careresponseservice delivery
项目摘要
Project Summary/Abstract
This application, responding to the Notice of Special Interest (NOSI) regarding the Availability
of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel
Coronavirus (NOT-DA-20-047), requests an administrative supplement to the Rural Expansion of
Medication Treatment for Opioid Use Disorder (Rural MOUD, CTN-0102). The main purpose of the
parent project is to investigate the impact of telemedicine (TM) on MOUD access and retention for
individuals with OUD in rural primary care settings. The coronavirus disease 2019 (COVID-19, or
COVID for short) pandemic has forced many health care systems to rapidly implement remote care
models, which is of direct relevance to this project. Building upon the existing research plan, we
request an administrative supplement to conduct a thorough investigation of COVID’s impact on TM
practices and access to MOUD in rural communities. In addition to characterizing changes in
attitudes and perceptions regarding TM for OUD treatment, we will investigate and assess the impact
of COVID over the next 2 years with regard to changes in MOUD access and services (especially TM)
in rural primary care settings and in OUD patients’ use of substances (particularly opioids) and health
conditions. Study specific aims include: Aim 1. To assess changes in MOUD access and services
(especially TM) in rural primary care settings over the COVID pandemic, and Aim 2. To assess
changes in OUD patients’ substance use (particularly opioids) and health conditions over the COVID
pandemic. The supplement funding will support (1) qualitative data collection and analysis that
includes focus groups and semi-structured interviews to document COVID impact from the
perspective of community stakeholders, providers, and patients drawn from primary care clinics
serving rural communities, and (2) quantitative data collection and analysis that includes health
records for patients served by the rural primary care clinics as well as self-report from OUD patients’
participant surveys to investigate COVID impact on the use of healthcare, TM, and substances.
Findings will contribute to scientific knowledge regarding COVID impact, responses, and
consequences in rural communities, as well as to inform and shape future development of remote
care models.
项目总结/摘要
本申请,响应关于可用性的特别利益通知(NOSI)
行政补充和紧急竞争性修订的研究2019小说
冠状病毒(NOT-DA-20 - 047),要求对农村扩张的行政补充,
阿片类药物使用障碍的药物治疗(农村MOUD,CTN-0102)。的主要目的
父项目是调查远程医疗(TM)对MOUD访问和保留的影响,
农村初级保健机构中的OUD患者。2019年冠状病毒病(COVID-19,或
COVID(简称COVID)大流行迫使许多医疗保健系统迅速实施远程护理
模型,这与该项目直接相关。根据现有的研究计划,我们
要求行政补充,以彻底调查COVID对TM的影响
在农村社区的实践和获得MOUD的机会。除了描述
态度和看法关于TM治疗OUD,我们将调查和评估的影响
未来2年新冠疫情在MOUD访问和服务(尤其是TM)方面的变化
农村初级保健环境和OUD患者使用药物(特别是阿片类药物)和健康
条件研究的具体目标包括:目标1。评估MOUD访问和服务的变化
(特别是TM)在农村初级保健环境中的COVID大流行,以及目标2。评估
OUD患者的物质使用(特别是阿片类药物)和健康状况在COVID期间的变化
流行病补充资金将支持(1)定性数据收集和分析,
包括焦点小组和半结构化访谈,以记录
社区利益相关者、提供者和来自初级保健诊所的患者的观点
服务农村社区,以及(2)定量数据收集和分析,包括健康
农村初级保健诊所服务的患者记录以及OUD患者的自我报告
参与者调查,以调查COVID对医疗保健,TM和物质使用的影响。
研究结果将有助于科学知识有关COVID的影响,反应,
农村社区的影响,以及为偏远地区的未来发展提供信息和塑造
护理模式
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YIH-ING HSER其他文献
YIH-ING HSER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YIH-ING HSER', 18)}}的其他基金
Greater Southern California Node of the Clinical Trials Network
临床试验网络大南加州节点
- 批准号:
10336684 - 财政年份:2019
- 资助金额:
$ 12.09万 - 项目类别:
Greater Southern California Node of the Clinical Trials Network
临床试验网络大南加州节点
- 批准号:
10359088 - 财政年份:2019
- 资助金额:
$ 12.09万 - 项目类别:
Greater Southern California Node of the Clinical Trials Network
临床试验网络大南加州节点
- 批准号:
10581587 - 财政年份:2019
- 资助金额:
$ 12.09万 - 项目类别:
Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder
阿片类药物使用障碍药物辅助治疗的患者决策辅助
- 批准号:
9765292 - 财政年份:2017
- 资助金额:
$ 12.09万 - 项目类别:
Real-Time Assessment of Triggers and Coping Responses in China
中国触发因素和应对反应的实时评估
- 批准号:
8507196 - 财政年份:2012
- 资助金额:
$ 12.09万 - 项目类别:
Neurocognitive Mechanisms and Recovery from Addiction
神经认知机制和成瘾恢复
- 批准号:
8389493 - 财政年份:2012
- 资助金额:
$ 12.09万 - 项目类别:
Real-Time Assessment of Triggers and Coping Responses in China
中国触发因素和应对反应的实时评估
- 批准号:
8382823 - 财政年份:2012
- 资助金额:
$ 12.09万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 12.09万 - 项目类别: